$GLSI This is the Michael Burry moment for those already in without the circus. When a biotech stops using the soft language of “exploring strategic alternatives” and starts signaling “seriousness of discussions” / “seriousness of interest,” it isn’t PR fluff. Under securities law it marks the shift into a material stage of negotiations: NDAs executed, real due diligence underway, preliminary term sheets being drafted. Most of the market will ignore it or lag. The people who are already positioned don’t need the noise. Quiet confirmation. Bullish.
View on X ↗